|
gptkbp:instanceOf
|
gptkb:disease
|
|
gptkbp:affects
|
humans
|
|
gptkbp:annualCasesWorldwide
|
1 billion
|
|
gptkbp:annualDeathsWorldwide
|
290,000-650,000
|
|
gptkbp:antiviralTreatment
|
gptkb:baloxavir_marboxil
gptkb:oseltamivir
gptkb:zanamivir
|
|
gptkbp:associatedWith
|
gptkb:avian_influenza
swine influenza
pandemic influenza
|
|
gptkbp:causedBy
|
gptkb:influenza_B_virus
gptkb:influenza_virus
influenza
|
|
gptkbp:complication
|
gptkb:pneumonia
death
hospitalization
|
|
gptkbp:contagiousPeriod
|
1 day before to 5-7 days after symptom onset
|
|
gptkbp:duration
|
about 1-2 weeks
|
|
gptkbp:firstDescribed
|
ancient times
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Seasonal influenza
|
|
gptkbp:ICD-10_code
|
gptkb:J11
J10
|
|
gptkbp:incubationPeriod
|
1-4 days
|
|
gptkbp:notableGroup
|
gptkb:H1N1
gptkb:H3N2
|
|
gptkbp:prevention
|
influenza
hand hygiene
|
|
gptkbp:publicHealthConcern
|
global
|
|
gptkbp:riskFactor
|
pregnant women
elderly
young children
immunocompromised individuals
|
|
gptkbp:season
|
autumn
winter
|
|
gptkbp:symptom
|
fever
fatigue
cough
muscle aches
sore throat
|
|
gptkbp:transmission
|
contact with contaminated surfaces
airborne droplets
|
|
gptkbp:treatment
|
supportive care
antiviral drugs
|
|
gptkbp:vaccineType
|
gptkb:inactivated_influenza_vaccine
gptkb:live_attenuated_influenza_vaccine
|
|
gptkbp:WHO_priority
|
high
|
|
gptkbp:bfsParent
|
gptkb:Avian_influenza
|
|
gptkbp:bfsLayer
|
4
|